With sites for residential buildings in desirable Manhattan neighborhoods increasingly scarce, developers are turning decrepit storage structures into housing. By Jane Margolies and Thea Traff Picking ...

“None of us have to be a complicit in the US and Israeli genocide. I worked [at] Microsoft… for seven years, and today I quit.” Use SecureDrop, an anonymity ...

Interactive platforms like Codecademy and Dataquest.io let you learn and code right in your browser, making python online practice easy and accessible. For structured learning, Coursera and the ‘Think ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Get seamless access to Morningstar data and the flexibility to use it in your favorite coding environments with the morningstar_data Python package. This new way to experience Direct lets you save ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

Real Housewives of Atlanta's Kandi Burruss, who announced her split from husband of 11 years Todd Tucker on Nov. 21, shared that their divorce has been a long time coming. Days after ‘Real Housewives ...

The talk/variety series “Real Time with Bill Maher,” hosted by Bill Maher, has been running for nearly two decades now, and is showing no signs of slowing down. In fact, HBO has already renewed the ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...